CIK 0000320017 · Non-accelerated filer<br>Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222343568
- Phone
- 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- 8-K Event Results of operations · Executive or director change · Regulation FD disclosure
- 4 Grant or award Director acquired 79,470 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 55,525 shares at $1.80 ($99,945)
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Grant or award Director acquired 51,063 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- D Other Notice of Sales of Unregistered Securities
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Unregistered share sale
- EFFECT Other Notice of Effectiveness
Page 14 of 80 · 1,585 filings